Docetaxel-based chemotherapy as second-line treatment for paclitaxel-based chemotherapy-resistant hormone-refractory prostate cancer: a pilot study.
暂无分享,去创建一个
K. Shigeno | H. Shiina | M. Igawa | N. Kikuno | S. Urakami | S. Honda | H. Kishi | Tateki Yoshino | S. Imai | T. Yoneda | Shin Imai